Stem cells aim to rescue lungs in Life-Threatening ARDS trial
Disease control
Not yet recruiting
This study tests a new stem cell therapy called JadiCell for people with acute respiratory distress syndrome (ARDS), a severe lung condition. The treatment is given through a vein and is designed to calm inflammation and help lung tissue heal. The trial will include 128 hospitali…
Phase: PHASE3 • Sponsor: Breathe Biologics, Inc. • Aim: Disease control
Last updated May 13, 2026 16:03 UTC